Illuminated microcatheter significantly lowers IOP in trabeculotomy

Article

Circumferential trabeculotomy performed with an illuminated microcatheter causes a significant reduction in IOP in glaucoma patients.

Circumferential trabeculotomy performed with an illuminated microcatheter causes a significant reduction in IOP in glaucoma patients, according to a study featured in the Journal of Glaucoma.

Dr C.A. Girkin et al., Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Alabama, USA, conducted a retrospective chart study on 11 eyes from 7 patients with primary or secondary congenital or juvenile glaucoma.

All patients underwent circumferential trabeculotomy with an illuminated microcatheter and eyes with six or more months of IOP data were included in the study. An IOP of lower than 21 mmHg was considered a success and a 30% IOP reduction without the use of IOP-lowering medications was also considered a success.

Mean IOP was 33.8±6.3 preoperatively and 18.3±3.5 at the final postoperative follow-up visit. Qualified success was demonstrated in 90.1% of eyes and unqualified success was reported in 81.8% of eyes. There were no long-term surgical complications.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.